JP Stock MarketDetailed Quotes

4565 Nxera Pharma

Watchlist
  • 1680
  • -22-1.29%
20min DelayNot Open Jul 31 15:00 JST
151.04BMarket Cap-19270P/E (Static)

Nxera Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nxera Pharma Earnings Date

Currency: JPY

Period

Q2 FY2024 Estimates

Aug 9, 2024

Revenue(YoY)

8.50B

0.00%
EPS(YoY)

14.18

0.00%
Analyst Rating

Buy

Jul 17, 2024

Nxera Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.600B--
Aug 9, 20242024/Q2-- / 8.500B--
May 9, 20242024/Q14.611B / 11.300B--
Feb 13, 20242023/Q47.292B / 13.254B--
Nov 10, 20232023/Q33.328B / 7.000B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 16.600B--
Aug 9, 20242024/Q2-- / 8.500B--
May 9, 20242024/Q14.611B / 11.300B--
Feb 13, 20242023/Q47.292B / 13.254B--
Nov 10, 20232023/Q33.328B / 7.000B--

Unlock Free Earnings Estimates

Nxera Pharma Earnings Reports

  • Sosei Group: Confirmation letter

    May 9 02:49 ET

  • Sosei Group: Quarterly Report - 35th Quarter 1 (2024/01/01 to 2024/03/31)

    May 9 02:48 ET

  • Sosei Group: Business highlights and consolidated financial results for the first quarter (January-March) of the fiscal year ending 2024/12

    May 9 02:30 ET

  • Sosei Group: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

    May 9 02:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 17, 2024

    Buy

    • Strong Buy

      55.56%

    • Buy

      22.22%

    • Hold

      22.22%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg